Role of matrix metalloproteinase-9 in a mouse model for amyotrophic lateral sclerosis

NeuroReport

Volumn 16, Issue 4, 2005, Pages 321-324

  Dewil, Maarten ^a   Schurmans, Céline ^a   Starckx, Sofie ^b   Opdenakker, Ghislain ^b   Van Den Bosch, Ludo ^a   Robberecht, Wim ^a  

^a Laboratory for Neurobiology   (Belgium)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Amyotrophic lateral sclerosis; Glia; Inflammation; Matrix metalloproteinase 9; Microglia; Motor neuron

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; GELATINASE B;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SYNTHESIS; IN VITRO STUDY; KNOCKOUT GENE; MICROGLIA; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SURVIVAL RATE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ASTROCYTES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MICROGLIA; SUPEROXIDE DISMUTASE;

EID: 15944379637     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200503150-00003     Document Type: Article

References (25)

1. Bruijn LI, Miller TM, Cleveland DW. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 2004; 27:723-749.
2. Rosen DR, Bowling AC, Patterson D, Usdin TB, Sapp P, Mezey E et al. A frequent ala 4 to val superoxide dismutase-1 mutation is associated with a rapidly progressive familial amyotrophic lateral sclerosis. Hum Mol Genet 1994; 3:981-987.
3. Turner MR, Cagnin A, Turkheimer FE, Miller CC, Shaw CE, Brooks DJ et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis 2004; 15:601-609.
4. Henkel JS, Engelhardt JI, Siklos L, Simpson EP, Kim SH, Pan T et al. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol 2004; 55:221-235.
5. Alexianu ME, Kozovska M, Appel SH. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology 2001; 57:1282-1289.
6. Cuzner ML, Gveric D, Strand C, Loughlin AJ, Paemen L, Opdenakker G et al. The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: comparison of stages in lesion evolution. J Neuropathol Exp Neurol 1996; 55:1194-1204.
7. Gu Z, Kaul M, Yan B, Kridel SJ, Cui J, Strongin A et al. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 2002; 297:1186-1190.
8. Lukes A, Mun-Bryce S, Lukes M, Rosenberg GA. Extracellular matrix degradation by metalloproteinases and central nervous system diseases. Mol Neurobiol 1999; 19:267-284.
9. Yong VW, Power C, Forsyth P, Edwards DR. Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2001; 2:502-511.
10. 10'. Asahi M, Asahi K, Jung JC, del Zoppo GJ, Fini ME, Lo EH. Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab 2000; 20:1681-1689.
11. Lorenzl S, Albers DS, Relkin N, Ngyuen T, Hilgenberg SL, Chirichigno J et al. Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease. Neurochem Int 2003; 43: 191-196.
12. Siao CJ, Tsirka SE. Extracellular proteases and neuronal cell death. Cell Mol Biol (Noisy-le-grand) 2002; 48:151-161.
13. Van den Steen PE, Dubois B, Nelissen I, Rudd PM, Dwek RA, Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol 2002; 37:375-536.
14. Lim GP, Backstrom JR, Cullen MJ, Miller CA, Atkinson RD, Tokes ZA. Matrix metalloproteinases in the neocortex and spinal cord of amyotrophic lateral sclerosis patients. J Neurochem 1996; 67:251-259.
15. Forsyth PA, Wong H, Laing TD, Rewcastle NB, Morris DG, Muzik H et al. Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br J Cancer 1999; 79:1828-1835.
16. Johnson C, Sung HJ, Lessner SM, Fini ME, Galis ZS. Matrix metalloproteinase-9 is required for adequate angiogenic revascularization of ischemic tissues: potential role in capillary branching. Circ Res 2004; 94:262-268.
17. Chambaut-Guerin AM, Herigault S, Rouet-Benzineb P, Rouher C, Lafuma C. Induction of matrix metalloproteinase MMP-9 (92-kDa gelatinase) by retinoic acid in human neuroblastoma SKNBE cells: relevance to neuronal differentiation. J Neurochem 2000; 74:508-517.
18. Dubois B, Masure S, Hurtenbach U, Paemen L, Heremans H, van den OordJ et al. Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. J Clin Invest 1999; 104:1507-1515.
19. Dubois B, Starckx S, Pagenstecher A, Oord J, Arnold B, Opdenakker G. Gelatinase B deficiency protects against endotoxin shock. Eur J Immunol 2002; 32:2163-2171.
20. Van Den Bosch L, Tilkin P, Lemmens G, Robberecht W. Minocycline delays disease onset and mortality in a transgenic model of ALS. Neuroreport 2002; 13:1067-1070.
21. Tortarolo M, Veglianese P, Calvaresi N, Botturi A, Rossi C, Giorgini A et al. Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression. Mol Cell Neurosci 2003; 23:180-192.
22. Van Den Bosch L, Schwaller B, Vleminckx V, Meijers B, Stork S, Ruehlicke T et al. Protective effect of parvalbumin on excitotoxic motor neuron death. Exp Neurol 2002; 174.
23. Hall ED, Oostveen JA, Gurney ME. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 1998; 23:249-256.
24. Zhang X, Cheng M, Chintala SK. Kainic acid-mediated upregulation of matrix metalloproteinase-9 promotes retinal degeneration. Invest Ophthalmol Vis Sci 2004; 45:2374-2383.
25. Beuche W, Yushchenko M, Mader M, Maliszewska M, Felgenhauer K, Weber F. Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis. Neuroreport 2000; 11:3419-3422.